Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.48 |
| ▸ | DRD3 | P35462 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | EDNRB | P24530 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MC4R | P32245 | 1/20 | 0.48 |
| ▸ | MC3R | P41968 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.47 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL637452 | 1.00 | CYP2C19 (0.53) | CYP2C19SMN1; SMN2CYP1A2CYP2D6PKM | |
| SCHEMBL1231305 | 1.00 | CYP2C19 (0.53) | CYP2C19SMN1; SMN2CYP1A2CYP2D6PKM | |
| SCHEMBL59840 | 0.84 | GABBR2 (0.59) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| SCHEMBL288753 | 0.84 | GABBR2 (0.59) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| SCHEMBL123765 | 0.84 | GABBR2 (0.59) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| SCHEMBL28450957 | 0.84 | GABBR2 (0.48) | CYP2C19SMN1; SMN2CYP2D6LMNAMAPK1 | |
| Hydrochloric Acid SCHEMBL2934796 | 0.83 | GABBR2 (0.57) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| SCHEMBL22685292 | 0.83 | GABBR2 (0.47) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| SCHEMBL9386161 | 0.83 | GABBR2 (0.57) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 | |
| Hydrochloric Acid SCHEMBL3874351 | 0.83 | GABBR2 (0.57) | CYP2C19SMN1; SMN2CYP2D6GABBR2GABBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2238137-A1 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS | IRM LLC (BM) | 2010-10-13 | — | — | EP | claimed |
| WO-2009097287-A1 | COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS | IRM LLC (BM) | 2009-08-06 | — | — | WO | claimed |
| EP-0071926-B1 | NEW RIBOFURANURONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-10-08 | — | — | EP | claimed |
| EP-0071926-A1 | New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-02-16 | — | — | EP | claimed |
| CN-109863131-B | Method for preparing cyclopropanecarboxylic acid | 美国陶氏益农公司 | 2022-04-05 | — | — | CN | disclosed |
| CN-110028422-A | A kind of method of imidazole hydrochloride catalytic amino protection | 重庆医科大学 | 2019-07-19 | — | — | CN | disclosed |
| CN-109863131-A | Prepare the phenyl that (1R, 3R) -2,2- dihalo -3-(replaces) phenyl that replaces of cyclopropane-carboxylic acid and (1S, 3S) -2,2- dihalo -3-() cyclopropane-carboxylic acid method | 美国陶氏益农公司 | 2019-06-07 | — | — | CN | disclosed |
| CN-105732414-B | The method of control of amide derivatives, the noxious organism control agent containing the amide derivatives and harmful organism | 三井化学AGRO株式会社 | 2019-05-03 | — | — | CN | disclosed |
| CN-105646637-B | A kind of abiraterone derivative and preparation method thereof and medical usage | 四川海思科制药有限公司 | 2018-12-14 | — | — | CN | disclosed |
| CN-108929311-A | 2- (2,4,5- substituted aniline) pyrimidine derivatives | 焦玉奇 | 2018-12-04 | — | — | CN | disclosed |
| CN-103554143-B | The CYCLOBUTYLETHYL boronic acid derivatives of 1 amino 2 | 米伦纽姆医药公司 | 2018-02-23 | — | — | CN | disclosed |
| CN-107043369-A | 2 (2,4,5 substituted aniline) pyrimidine derivatives | 焦玉奇 | 2017-08-15 | — | — | CN | disclosed |
| EP-0885186-A1 | AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM | Dr. Karl Thomae GmbH (DE) | 1998-12-23 | — | — | EP | disclosed |
| WO-1997019911-A1 | AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND PROCESSES FOR PREPARING THEM | DR. KARL THOMAE GMBH (DE) | 1997-06-05 | — | — | WO | disclosed |
| CN-1092410-A | Inhibitors of HIV protease as the treatment AIDS | LILLY CO ELI (US) | 1994-09-21 | — | — | CN | disclosed |
| CN-1071930-A | Inhibitor as the human immunodeficiency virus protease who treats acquired immune deficiency syndrome (AIDS) | LILLY CO ELI (US) | 1993-05-12 | — | — | CN | disclosed |
| EP-0071926-B1 | NEW RIBOFURANURONIC ACID DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREOF | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-10-08 | — | — | EP | disclosed |
| US-4479942-A | Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-30 | — | — | US | disclosed |
| EP-0071926-A1 | New ribofuranuronic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-02-16 | — | — | EP | disclosed |
| EP-0005070-A2 | N-(2-thiazolyl)amides and their use as anti-inflammatory and immunoregulatory agents | PFIZER INC. (US) | 1979-10-31 | — | — | EP | disclosed |